I S Weimar - JoVE Visualize

Showing results (1-10 of 8) with videos related to

Pageof 1

Sort By:

Leukemia & Lymphoma|April 1, 1994

Clonality in myelodysplastic syndromesI S Weimar, J H Bourhis, G C De Gast, et al.

Immunobiology|November 1, 1992

Effector cells of low-dose IL-2 immunotherapy in tumor bearing mice: tumor cell killing by CD8+ cytotoxic T lymphocytes and macrophagesR A Maas, P A Roest, M J Becker, et al.

Immunobiology|July 1, 1993

Transfer of tumor immunity by both CD4+ and CD8+ tumor infiltrating T lymphocytes activated in vivo by IL-2 therapy of tumor bearing miceR A Maas, M J Becker, I S Weimar, et al.

Experimental Hematology|August 7, 1998

Hepatocyte growth factor/scatter factor (HGF/SF) is produced by human bone marrow stromal cells and promotes proliferation, adhesion and survival of human hematopoietic progenitor cells (CD34+)I S Weimar, N Miranda, E J Muller, et al.

Blood|February 1, 1997

Hepatocyte growth factor/scatter factor promotes adhesion of lymphoma cells to extracellular matrix molecules via alpha 4 beta 1 and alpha 5 beta 1 integrinsI S Weimar, D de Jong, E J Muller, et al.

Leukemia|August 11, 1998

Hepatocyte growth factor/scatter factor (HGF/SF) affects proliferation and migration of myeloid leukemic cellsI S Weimar, C Voermans, J H Bourhis, et al.

British Journal of Cancer|September 16, 1999

HGF/SF and its receptor c-MET play a minor role in the dissemination of human B-lymphoma cells in SCID miceI S Weimar, K Weijer, P C van den Berk, et al.

Blood|November 15, 1995

The value of flow cytometric analysis of platelet glycoprotein expression of CD34+ cells measured under conditions that prevent P-selectin-mediated binding of plateletsM W Dercksen, I S Weimar, D J Richel, et al.

Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:

Pageof 1

Leukemia & Lymphoma|April 1, 1994

Clonality in myelodysplastic syndromesI S Weimar, J H Bourhis, G C De Gast, et al.

Immunobiology|November 1, 1992

Effector cells of low-dose IL-2 immunotherapy in tumor bearing mice: tumor cell killing by CD8+ cytotoxic T lymphocytes and macrophagesR A Maas, P A Roest, M J Becker, et al.

Immunobiology|July 1, 1993

Transfer of tumor immunity by both CD4+ and CD8+ tumor infiltrating T lymphocytes activated in vivo by IL-2 therapy of tumor bearing miceR A Maas, M J Becker, I S Weimar, et al.

Experimental Hematology|August 7, 1998

Hepatocyte growth factor/scatter factor (HGF/SF) is produced by human bone marrow stromal cells and promotes proliferation, adhesion and survival of human hematopoietic progenitor cells (CD34+)I S Weimar, N Miranda, E J Muller, et al.

Blood|February 1, 1997

Hepatocyte growth factor/scatter factor promotes adhesion of lymphoma cells to extracellular matrix molecules via alpha 4 beta 1 and alpha 5 beta 1 integrinsI S Weimar, D de Jong, E J Muller, et al.

Leukemia|August 11, 1998

Hepatocyte growth factor/scatter factor (HGF/SF) affects proliferation and migration of myeloid leukemic cellsI S Weimar, C Voermans, J H Bourhis, et al.

British Journal of Cancer|September 16, 1999

HGF/SF and its receptor c-MET play a minor role in the dissemination of human B-lymphoma cells in SCID miceI S Weimar, K Weijer, P C van den Berk, et al.

Blood|November 15, 1995

The value of flow cytometric analysis of platelet glycoprotein expression of CD34+ cells measured under conditions that prevent P-selectin-mediated binding of plateletsM W Dercksen, I S Weimar, D J Richel, et al.

Pageof 1